Clinical Trials Browser

Phase 4 × apatinib × Lymphoid × Clear all

NCT03376958 2019-07-25

Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma

Phase 4 Completed

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03631862 2018-08-15

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Phase 4 Unknown

Lymphoma, T-Cell, Peripheral